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ABSTRACT
Despite gains in controlling mortality relating to diarrhoeal disease, the burden of disease remains unacceptably high. To refocus health research to target disease-burden reduction as the goal of research in child
health, the Child Health and Nutrition Research Initiative developed a systematic strategy to rank health
research options. This priority-setting exercise included listing of 46 competitive research options in diarrhoeal disease and their critical and quantitative appraisal by 10 experts based on five criteria for research
that reflect the ability of the research to be translated into interventions and achieved disease-burden reduction. These criteria included the answerability of the research questions; the efficacy and effectiveness
of the intervention resulting from the research; the maximal potential for disease-burden reduction of the
interventions derived from the research; the affordability, deliverability, and sustainability of the intervention
supported by the research; and the overall effect of the research-derived intervention on equity. Experts
scored each research option independently to delineate the best investments for diarrhoeal disease control
in the developing world to reduce the burden of disease by 2015. Priority scores obtained for health policy
and systems research obtained eight of the top 10 rankings in overall scores, indicating that current investments in health research are significantly different from those estimated to be the most effective in reducing the global burden of diarrhoeal disease by 2015.
Key words: Child heath; Diarrhoeal diseases; Mortality; Priority setting; Medical research

INTRODUCTION
Diarrhoeal disease causes an estimated 1.8 million
deaths per year (1). Despite evidence of reduction
in mortality over the last 50 years (2,3), diarrhoeal
disease continues to be a major killer of children
aged less than five years and a principal cause of
morbidity for most impoverished children of the
world. It is well-known that most of these deaths
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are preventable with existing disease- control strategies (4).
Although there are numerous causes for the lack of
greater progress in the control of diarrhoeal diseases, it is clear that our investments in related research
over the last 20 years have not had the greatest attainable impact. It is now increasingly recognized
that research priorities do not optimally address the
needs of children in developing countries (5,6). Setting research priorities is clearly a challenging and
imperfect process that relies on the best data available and the knowledge of experts in the field to
fill in knowledge gaps. Clearly, data regarding the
number and cause of deaths and the coverage of
interventions are limited and imperfect. How to
integrate available data with expert opinion is an
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evolving area. Classically, they were derived from
expert group meetings and, more recently, Delphi exercises have been employed as an improved
strategy to incorporate expert opinion in decisionmaking processes. Cost-effectiveness analyses have
been used for prioritizing among health interventions but have not been systematically used for
determining the most promising research. In any
case, cost-effectiveness analysis would have limited
usefulness without a critical assessment of the likelihood that investments in research would result
in reduction in the burden of disease. The Child
Health and Nutrition Research Initiative (CHNRI)
was founded to encourage and support research on
the important child health problems in low- and
middle-income countries. The CHNRI developed a
structured process that was designed to measure the
likelihood that funding-specific research questions
would be successful in reducing child morbidity
and mortality. This novel methodology was used
here for assessing the priority for funding particular
avenues of research to address the burden of disease
caused by childhood diarrhoea (7,8).

MATERIALS AND METHODS
Selection of group members and research
options
As part of a larger exercise of assessing research
priorities for major child health conditions, the
CHNRI decided that the exercise should consider
research for burden of reduction of diarrhoeal disease by 2015 among children aged less than five
years. Since the currently-accepted disease-burden
measure is the disability-adjusted life-year (DALY),
which incorporated both mortality and morbidity components of disease, our scoring exercise included both mortality and morbidity components.
However, due to the current thinking on disease
weighting, most burden of diarrhoeal disease is related to mortality rather than morbidity, and scorers were asked to respect this current thinking. The
CHNRI Secretariat selected two group members (CL
and MK). These two members defined the list of
research options in communication with IR, based
on a systematic framework for listing research options relating to a single disease developed by the
CHNRI (7,8). This systematic approach enables
comprehensive listing and equal treatment of research options in different broad research domains:
epidemiologic research, health policy and systems
research (HSPR), research intended to improve existing interventions, and research to develop new
interventions. The list of research questions was
intentionally limited to less than 50 to allow individuals to be able to complete the scoring process
320
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in a single day. These research options included
different strategies in diarrhoeal disease control encompassing those aimed at improving water and
sanitation infrastructure, those targeting healthcare-delivery strategies, those addressing nutritional deficiencies, and research to evaluate novel diagnostics and vaccines. The research options were
then categorized as either: (a) Health policy and
systems research (HSPR) that aimed to improve the
efficiency and coverage of known interventions; (b)
Research that improved existing interventions by
making them more affordable or deliverable; or (c)
Research options to develop entirely new interventions. Although a research option could encompass
multiple different research questions, it was made
sufficiently narrow in scope to be able to anticipate
specific research project derivatives that could be
evaluated by the scoring process.
A further 17 experts were invited to participate,
of whom eight completed and returned priority
scores for a total group of scorers comprising 10
individuals [Group of scorers: Shinjini Bhatnager,
Zulfiqar A. Bhutta, Olivier Fontaine, Margaret Kosek, Claudio F. Lanata, Dilip Mahalanabis, Mohammed Abdus Salam, John D. Snyder, Cesar Victora,
and Damian G. Walker].
These individuals were categorized as physicians
with expertise in infectious diseases, gastroenterologists, public-health researchers specialized in programmatic issues, a health economist, and publichealth researchers in areas other than programme
development and evaluation. Each one scored the
individual research options independently using a
five-component structured model developed by the
CHNRI to evaluate health research. The five components consist of the following: (a) likelihood that the
research option can yield new knowledge in an ethical manner; (b) likelihood that the research findings
will lead to efficacious and effective interventions;
(c) likelihood that the intervention derived from the
research would be affordable and deliverable to the
population of interest; (d) most likely maximum
burden of disease reduction that could be derived
from interventions resulting from research within
the option; and (e) likely impact that the derivates of
the research will have on equity.
Scores were computed as percentage of maximal
obtainable points for each of the major five components being evaluated and then combined for an
overall score. The scores outline both limitations
and strengths of each research option. Each of the
five intermediate scores reflect the likelihood that
the research option will be answerable, that it will
result in an effective intervention, that the resultJHPN
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ing intervention will be deliverable, that the resulting intervention will increase equity, and an estimation of the maximal disease-burden impact an
intervention resulting from the research is foreseen
to have. When added together, this overall score
becomes a quantitative measure of the collective
optimism that research in that area can have substantial impact prior to 2015. Although this system
easily accommodates weighting of these five options by donors or regional agencies or other stakeholders, we have presented the unweighted results.
The process of scoring is presented in greater detail
elsewhere (7-10).

RESULTS
The listing of research options yielded 46 options.
Twenty-one research options were designed as
health policy and systems research to increase the
efficiency of interventions already in place, 10
options addressed research to improve the affordability and deliverability of known interventions,
and 15 options were primary research to develop
new interventions. The complete list of the 46 research options is presented in Table 1. The questions guiding the scoring of the research options
by each criteria are shown in Table 2. An excel file
that facilitates the scoring exercise by providing a
spreadsheet for the input of scores is available online (http://www.icddrb.org/jhpn).

Criterion 1: Generating new knowledge
Priority scores for research options evaluated solely
on the criterion of their ability to generate new
knowledge ranged from 57.0% to 95.8%. The top
five research options that were predicted to encounter minimal obstacles in their realization are
listed in Table 3. The research option that received
the highest score for this criterion was the conduction of cost-effectiveness studies of rotavirus vaccines in different epidemiologic contexts. The second ranked research option by this criterion was
effectiveness studies to evaluate the expanded use
of low-osmolarity oral rehydration solution (ORS).
Two research alternatives received equal scores to
rank third. These options included health policy
and systems research to improve the deliverability
and cost of zinc treatment in diarrhoeal disease programmes and health policy and systems research to
improve coverage of rotavirus vaccine in countries
with the greatest burden of disease. Health policy
and systems research to improve case management
of moderate and severe cases of diarrhoeal illness
by using standardized case management and the
development of new antibiotics for the treatment
Volume 27 | Number 3 | June 2009
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of drug-resistant shigellosis tied for fourth place in
the ranking. The fifth rank was occupied by two
evenly-ranked options of health policy and services
research to increase access to ORS envelops at all
times to all children who need it and health policy
and services research to increase the percentage of
infants exclusively breastfed up to the age of six
months.
Low scoring research options in this category were
predominated by enteric vaccines that are currently
in early stages of development as these are unlikely
to yield clinical trials demonstrating efficacy prior
to 2015. Scores for Campylobacter, enteropathogenic Escherichia coli, Entamoeba histolytica, and norovirus all obtained scores for answerability ranging
between 57% and 68%.

Criterion 2: Efficacy and effectiveness
The priority scoring of research options based solely
on their predicted potential to lead to (or improve)
efficacious and effective interventions yielded
scores ranging from 32.0% to 97.9% (Table 4). The
top research option when judged by this criterion
was the study of cost-effectiveness of rotavirus vaccine in different epidemiologic contexts. The second-ranking research option was health policy and
services research to increase the access to ORS for
all children who may need it. Effectiveness, health
policy and services research, and educational/behavioural modification studies to improve the deliverability and cost of zinc treatment in diarrhoeacontrol programmes in several regions of the world
with different epidemiologic profiles occupied the
third rank. Tied for the fourth ranking was research
to generate new knowledge (mostly effectiveness
studies) to increase use of low-osmolarity ORS and
health systems research to increase the coverage of
measles vaccine. The fifth-ranking research option
in terms of efficacy and effectiveness was health
policy and systems research to improve the quality
of care of moderate/severe diarrhoea cases through
standardized case management.
Research options that received low scores in this
area were diverse and included research relating to fly control, the improved storage of weaning foods, and the development of interventions
meant to curb bacterial contamination of crops.

Criterion 3: Sustainability and deliverability
Priority scores for options evaluated based on sustainability and deliverability alone had the widest
variation in obtained scores of the five criteria with
scores ranging from 9% to 90%. The highest score
321
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Table 1. List of 46 research options scored by diarrhoeal disease experts
Research option
RO1 : Health policy and systems research (HPSR) to increase access to ORS packets at all times in
all sites for all children who may need it
RO2 : Research to generate new knowledge (mostly effectiveness studies) to increase the use of
low-osmolarity ORS
RO3 : Health policy, systems, and education/behaviour modification research to increase the
percentage of infants with exclusive breastfeeding at <6 month of age
RO4 : Health policy, systems, and education/behaviour modification research to increase the percentage of infants and children, aged less than 2 years, who are breastfed
RO5 : Health system research to increase the coverage of measles vaccine
RO6 : HPSR to improve the coverage of rotavirus vaccine in countries with the greatest needs
RO7 : Systems and education/behaviour modification research to increase water consumed per
person per day
RO8 : System research to measure the effectiveness of piped water systems on diarrhoea if they
are installed at the community vs in the home
RO9 : System research to measure the effectiveness of piped water systems on diarrhoea if they
are installed so as to provide intermittent vs 24-hour availability
RO10 : Systems and education/behaviour modification research to increase the coverage of sewage systems
RO11: Systems and education/behaviour modification research to increase the prevalence of effective latrines
RO12 : Health policy, systems, and education/behaviour modification research to increase the proportion
of women and children washing their hands effectively to improve hand-washing promotion
RO13 : Education/behaviour modification research to increase the energy density of weaning foods at
the household level (in areas with food availability)
RO14: HPSR to allow that all mothers with a child with diarrhoea will know how to recognize dangersigns for timely referral/self-referral of severe cases
RO15: HPSR to improve the quality of care of moderate/severe diarrhoea cases through standardized case management
RO16: HPSR to improve prescription of appropriate antibiotics for dysentery
RO17 : Efficacy/effectiveness studies of interventions of behaviour modification to reduce baby bottle-use
RO18: Education/behaviour modification research to increase the use of refrigerators for storage
of weaning foods
RO19: Efficacy/effectiveness studies and education/behaviour modification research to increase
consumption of Lactobacillus GG probiotic
RO20: Efficacy/effectiveness studies of interventions of behaviour modification to increase potties-use/improved faece-disposal practices
RO21: HPSR to generate new knowledge to increase the coverage of vitamin A supplementation
RO22: System and community research to reduce costs/improve deliverability and increase the
coverage of piped water systems
RO23: Effectiveness, costs, sustainability, system and behavioural modification/cultural research
to increase the use of point-of-use water disinfection: implementation of point-of-use treatment and water-storage practices
RO24: Research to develop new ways of sewage-treatment systems that will make them affordable
to developing countries
RO25: Research to improve the deliverability, measure effectiveness, and determine the sustainability of
fly-control interventions
RO26: Effectiveness studies and studies that will reduce the cost/improve the deliverability of
cholera vaccines in high-burden countries
RO27: Cash-transfer programmes to improve diet quality and nutrition in poor areas
RO28: Policy, systems, and education/behaviour modification research to improve current strategies
aiming at improving the quality of diet of family in areas with low access to good diets
Contd.
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Table 1—Contd.
RO29: Effectiveness, HPSR, and educational/behaviour modification studies to improve the deliverability/cost of zinc treatment in diarrhoea-control programmes in several regions of
the world with different epidemiological profiles
RO30: Efficacy, effectiveness and cost studies that will increase the use of zinc food-fortification
programmes in developing countries
RO31: Cost-effectiveness studies of rotavirus vaccine in different epidemiologic contexts
RO32: Develop norovirus vaccines
RO33: Develop Shigella vaccines
RO34: Develop ETEC vaccines
RO35: Develop Campylobacter vaccines
RO36: Develop EPEC vaccines
RO37: Develop Helicobacter pylori vaccines
RO38: Develop vaccines for Entamoeba histolytica
RO39: Develop new measles vaccines that will be heat-stable and able to immunize newborns
RO40: Solar ovens to keep weaning foods above >50 0C for a day
RO41: Low cost, no electrical/no fuel consuming refrigerators to storage food at the household level
RO42: New antibiotics for drug-resistant Shigella
RO43: New antibiotics for drug-resistant cholera
RO44: Develop interventions that will reduce bacterial contamination of crops irrigated with
contaminated water in developing countries
RO45: Further development of antisecretory agents in the management of paediatric diarrhoea
RO46: Develop the technology to deliver zinc to children using prolong dosing intervals
EPEC=Enteropathogenic Escherichia coli; ETEC=Enterotoxigenic Escherichia coli; ORS=Oral rehydration solution; RO=Research option
in terms of sustainability and deliverability was
given to effectiveness studies to increase the use
of low-osmolarity ORS which obtained a priority
score of 90% (Table 5). The second ranking was
to studies relating to the uptake and evaluation of
zinc in diarrhea-control programmes in the different epidemiologic contexts. The third ranking
was shared by research options for health policy
and systems research to improve the prescription
of appropriate antibiotics for dysentery and to increase the coverage of vitamin A supplementation.
The evaluation of the cost-effectiveness of rotavirus
vaccine in the different epidemiologic contexts and
health policy and systems research to improve the
quality of care of moderate and severe diarrhoea
cases through standardized case management were
ranked fourth. The fifth-ranking option was health
policy, systems and education and behavioural
modification research to increase the proportion
of women and children washing their hands effectively.
Research options scoring poorly in deliverability
and sustainability included options to increase the
use of refrigerators for the storage of weaning foods,
cash-transfer programmes to improve the quality
of diet and nutrition in poor areas, and vaccines for
E. histolytica and Camplylobacter.
Volume 27 | Number 3 | June 2009

Criterion 4: Maximal potential for diseaseburden reduction
Priority scores to judge the maximum potential for
disease-burden reduction ranged from 8% to 79%
(Table 6). The top two scoring research options related to use of rotavirus vaccine. The top scoring
research option achieved a priority score of 79.2%
and was aimed at evaluating the cost-effectiveness
of rotavirus vaccination in the different epidemiologic contexts while health policy and systems research to improve the coverage of rotavirus vaccination in countries with the greatest need had a
76.7% priority score. Health policy and services research to increase access to ORS envelops received
the third-ranking position and was followed in the
ranking by health policy and services research to
improve the deliverability and cost of zinc treatment in diarrhoea-control programmes in several
regions of the world with different epidemiologic
profiles. The fifth-ranking option was health policy
and systems research to train mothers in the recognition of danger signs for the timely self-referral of
severe cases of diarrhoea.
Low scores in maximal potential for disease-burden reduction were obtained by research options
relating to fly-control interventions, effectiveness,
and deliverability of cholera vaccine, and efficacy
and effectiveness studies relating to use of probiotic
Lactobacillus GG.
323
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Question 1
1.1 Would you say the research
question is well-framed and
endpoints are well-defined?

2.1 Based on the best existing
evidence and knowledge, would
the intervention which would
be developed/improved through
proposed research be efficacious?
3.1 Taking into account the level
of difficulty with intervention
delivery from the perspective
of the intervention itself (e.g.
design, standardizability, safety),
the infrastructure required (e.g.
human resources, health facilities, communication and transport infrastructure) and users of
the intervention (e.g. need for
change of attitudes or beliefs,
supervision, existing demand),
would you say the endpoints of
the research would be deliverable within the context of interest?

Scoring criteria

Criteria 1: Likelihood that the research will lead to new knowledge
in an ethical way

Criteria 2: Assessment of the
likelihood that the intervention which would be developed
through the research would be
efficacious

Criteria 3: Likelihood that the intervention based on the research
would be affordable, deliverable,
and sustainable in the population
of interest

3.2 Taking into account the
resources available to implement the intervention, would
you say that the endpoints of
the research would be affordable within the context of
interest?

Contd.

3.3 Taking into account government capacity and partnership
requirements (e.g. adequacy
of government regulation,
monitoring, and enforcement;
governmental intersectoral
coordination, partnership with
civil society and external donor
agencies; favourable political climate to achieve high coverage),
would you say that the endpoints of the research would be
sustainable within the context
of interest?

2.3 Would you say that the
evidence upon which these
opinions are based (answers
to prior 2 questions) is of high
quality?

1.3 Do you think that a study
needed to answer the proposed research question
would obtain ethical approval
without major concerns?

1.2 Based on: (a) the level of existing
research capacity in proposed research and (b) the size of the gap
from current level of knowledge
to proposed endpoints, would
you say that a study can be
designed to answer the research
question and to reach the proposed endpoints of the research?
2.2 Based on the best existing
evidence and knowledge,
would the intervention which
would be developed/improved
through the proposed research be effective?

Question 3

Question 2

Table 2. Questions with which to assess the 5 criteria for each selected research option. For an interactive spreadsheet for scoring, see website
(http://www.icddrb.org/jhpn)
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5.1 Would you say that the
present distribution of the
disease burden affects mainly
the underpriveleged in the
population?

Criteria 5: Assessment of the
impact of proposed research on
equity

5.2 Would you say that either (a)
mainly the underpriveleged, or
(b) all segments of the society
equally would be the most likely
to benefit from the results of the
proposed research after its implementation?

4.2 To remove 10% or more?

2

2

4
2

3

4

4
5

RO6 : HPSR to improve coverage of rotavirus vaccine in countries with the greatest needs (impact on morbidity and mortality)
RO15: HPSR to improve the quality of care for moderate and severe diarrhoea cases through standardized
case management (impact on mortality only)

RO29: Effectiveness, health policy, and systems research (HPSR) and educational/behaviour modification
studies to improve the deliverability/cost of zinc treatment in diarrhoea-control programmes in several
regions of the world with different epidemiological profiles

RO42: New antibiotics for drug-resistant enteropathogens: Shigella
RO1 : HPSR to increase access to ORS packets at all times in all sites for all children who may need it
RO3 : Health policy, systems, and education/behaviour modification research to increase percentage of infants
5
2
with exclusive breastfeeding <6 months of age
ORS=Oral rehydration solution; RO=Research option

3

3

85.0

85.2
85.0

85.2

86.7

86.7

Score (%)
95.8
88.3

5.3 Would you say that the proposed research has the overall
potential to improve equity in
disease-burden distribution in
the long term (e.g. 10 years)?

4.3 To remove 15% or more?

Table 3. Top 5 options for generating new knowledge (Criterion 1)
Rank
Category
Research option
1
3
RO31: Cost-effectiveness studies of rotavirus vaccine in different epidemiologic contexts
2
2
RO2 : Research to generate new knowledge (mostly effectiveness studies) to increase the use of low-osmolarity ORS

4.1 Taking into account the results
of conducted intervention trials,
or for the new interventions the
proportion of avertable burden
under an ideal scenario, would
you say that the sucessful reaching of research endpoints would
have the capacity to remove 5%
of the burden or more?

Criteria 4: Assesment of the maximal potential for disease-burden
reduction

Table 2—Contd.
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Table 4. Top 5 options for efficacy/efficaciousness (Criterion 2)
Rank Category Research options
Score (%)
1
3
RO31: Cost-effectiveness studies of rotavirus vaccine in different
epidemiologic contexts
97.9
2
2
RO1 : HPSR to increase access to ORS packets at all times in all
sites for all children who may need it
93.3
3
3
RO29: Effectiveness, HPSR, and educational/behaviour modification
studies to improve the deliverability/cost of zinc treatment
in diarrhoea-control programmes in several regions of the
world with different epidemiological profiles
90.7
4
2
RO2 : Research to generate new knowledge (mostly effectiveness
studies) to increase use of low-osmolarity ORS
86.7
2
RO5 : Health-systems research to increase the coverage of mea4
sles vaccine
86.7
5
2
RO15 : HPSR to improve the quality of care for moderate and severe
diarrhoea cases through standardized case management
85.4
HPSR=Health policy and systems research; ORS=Oral rehydration solution; RO=Research option
Table 5. Top 5 options for sustainability and deliverability (Criterion 3)
Rank
Category Research option
1
2

2
3

3

2

3

2

RO2 : Research to generate new knowledge (mostly effectiveness
studies) to increase the use of low-osmolarity ORS
RO29: Effectiveness, HPSR, and educational/behaviour modification studies to improve the deliverability/cost of zinc
treatment in diarrhoea-control programmes in several
regions of the world with different epidemiological profiles
RO16: HPSR to improve prescription of appropriate antibiotics
for dysentery
RO21: HPSR to generate new knowledge to increase the coverage of vitamin A supplementation (to reduce severity of
diarrhoea and improve mortality)

Score (%)
90.0

88.9
85.2

85.2

4

3

RO31: Cost-effectiveness of rotavirus vaccine in different epidemiologic contexts

4

2

RO15: HPSR to improve the quality of care for moderate and severe
diarrhoea cases through standardized case management

83.3

5

2

RO12: Health policy, systems, and education/behaviour modification research to increase the proportion of women and
children washing their hands effectively

77.8

83.3

HPSR=Health policy and systems research; ORS=Oral rehydration solution; RO=Research option

Criterion 5: Equity
The scores for equity were the highest of any of the
criteria and ranged from 43.0% to 98.3%. All five
top options received priority scores greater than
90% (Table 7). The top score was given to health
systems research to increase the coverage of measles vaccine. The second-ranking research option
was policy, systems, and education and behaviour
modification research to improve current strategies
aiming at improving the quality of diet of families
326

in areas with low access to good diets. Systems and
education and behavioural modification research to
increase the prevalence of latrines was ranked third.
Educational and behavioural modification research
to increase the energy density of weaning foods at
the household level in areas with food availability
and systems and behavioural research to improve
water consumed per person per day obtained equal
scores to rank fourth among the selected research
options. The fifth-ranking option was health policy
and systems research to improve the quality of care
JHPN
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Table 6. Top 5 option for maximal potential to decrease disease burden (Criterion 4)
Rank Category Research option
1
3
RO31: Cost-effectiveness of rotavirus vaccine in different
epidemiologic contexts
2
2
R06 : HPSR to improve the coverage of rotavirus vaccine in
countries with the greatest needs
3

4

5

2

3

2

Score (%)
79.2
76.7

RO1 : Health policy and systems research (HPSR) to increase
access to ORS packets at all times in all sites for all children
who may need it

75.0

RO29: Effectiveness, HPSR, and educational/behaviour modification studies to improve the deliverability/cost of zinc treatment in diarrhoea-control programmes in several regions of
the world with different epidemiological profiles

70.0

RO14: HPSR to allow that all mothers with a child with diarrhoea
will know how to recognize danger-signs for timely referral/self-referral of severe cases

64.8

ORS=Oral rehydration solution; RO=Research option
of moderate and severe cases of diarrhoea through
standardized case management.
Low priority scores were obtained by research
options to evaluate probiotic Lactobacillus GG, new
antisecretory agents, and vaccines for E. histolytica,
norovirus, and H. pylori.

Combined results
The overall priority scores that were assigned to research options by computing unweighted means of
the five intermediate scores ranged from 35.0% to
85.2% (Table 8). The top scoring research items,
overall, were predominantly (7/10) options that
aimed at increasing the efficiency and coverage
of interventions with known effectiveness. The

research option receiving the highest priority score
addressed effectiveness, health policy and services
research to improve the deliverability and cost of
zinc treatment in diarrhoea-control programmes
in areas with different epidemiologic profiles. The
second-ranking research option, which proposed
conducting cost-effectiveness studies of rotavirus
vaccine in different epidemiologic contexts received
a priority score less than 1% lower than the topranking option. Health policy and services research
to increase access to ORS envelops and to improve
the quality of care of moderate to severe cases of
diarrhoea through standardized case management
were ranked third and fourth respectively. Effectiveness studies to increase the use of low-osmolarity
ORS received the fifth-ranking priority score and

Table 7. Top 5 options for equity (Criterion 5)
Rank
Category Research option
R05 : Health systems research to increase the coverage of mea1
2
sles vaccine
2

3

RO28: Policy, systems, and education/behaviour modification
research to improve current strategies aiming at improving the quality of diet of family in areas with low access
to good diets

RO11: Systems and education/behaviour modification research
to increase the prevalence of effective latrines
RO13: Education/behaviour modification research to increase the
4
2
energy density of weaning foods at the household level (in
areas with food availability)
RO7 : Systems and education/behaviour modification research
4
2
to improve water consumed per person per day
RO15: HPSR to the improve the quality of care for moderate and severe
5
2
diarrhoea cases through standardized case management
HPSR=Health policy and systems research; RO=Research option
3

2
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Score (%)
98.3

96.7
93.3
92.6
92.6
90.7

327

Research priorities for diarrhoeal disease

Kosek M et al.

Table 8. Top 10 research options overall by five criteria
Rank Category Research option
1

3

2

3

RO29 : Effectiveness, HPSR, and educational/behaviour modification
studies to improve the deliverability/cost of zinc treatment in
diarrhoea-control programmes in several regions of the world
with different epidemiological profiles

Score (%)

85.2

RO31: Cost-effectiveness studies of rotavirus vaccine in different
85.0
epidemiologic contexts
3
2
RO1 : Health policy and systems research (HPSR) to increase access to ORS packets at all times in all sites for all children
who may need it
81.6
4
2
RO15: HPSR to improve the quality of care for moderate/severe
diarrhoea cases through standardized case management
80.0
5
2
RO2 : Research to generate new knowledge (mostly effectiveness
studies) to increase the use of low-osmolarity ORS
78.7
6
2
RO3 : Health policy, systems, and education/behaviour modification research to increase the percentage of infants with
exclusive breastfeeding <6 months of age
77.4
7
2
RO5 : Health systems research to increase the coverage of measles vaccine
77.2
2
RO6 : HPSR to improve the coverage of rotavirus vaccine in
8
countries with the greatest needs
75.0
9
2
RO14: HPSR to allow that all mothers with a child with diarrhoea
will know how to recognize danger-signs for time referral/
self-referral of severe cases
74.4
10
3
RO30: Efficacy, effectiveness and cost studies that will increase the use
of zinc food-fortification programmes in developing countries
73.0
HPSR=Health policy and systems research; ORS=Oral rehydration solution; RO=Research option
was followed closely by health policy, systems, and
education and behavioural modification research
to increase the percentage of infants exclusively breastfed for the first six months of life. Health
systems research to increase the coverage of measles and rotavirus vaccines were ranked seventh
and eighth respectively. Health policy and systems research to aid mothers in the recognition of
danger-signs in cases of severe illness to improve
self-referral ranked ninth, and the tenth priority
ranking was assigned to efficacy, effectiveness and
costing studies to evaluate the increased use of zincfortification programmes in developing countries.

Vaccines
It is worth noting that the development of new
vaccines for the improved control of the burden
of diarrhoeal disease obtained low scores (Table 9).
The highest-scoring vaccine was a measles vaccine
that would be both heat-stable and effective when
administered in the neonatal period. Research directed towards obtaining this goal received a priority score of 65.1%. The highest-scoring vaccine directly targeting an enteric organism was a vaccine
against Shigella, which obtained a priority score of
63.0%. Determining the cost-effectiveness of the
328

currently-available cholera vaccine received a score
of 61.7%.
There is little question that the group of scorers was
not biased against vaccines as a whole or enteric
vaccines. Two of the overall top 10 research options
reflected research regarding the appropriate usage
of rotavirus vaccine in different settings. In addition to this, health policy and service research to
increase the coverage of the current measles vaccine was ranked seventh overall. In general, the
existing vaccines with proven efficacy and potential for expanded access were scored higher than
theoretical possibilities in vaccine research. Furthermore, as the time set to expect the benefits of
the research in terms of disease-burden reduction is
2015, this timetable challenges vaccine research in
areas in which knowledge on basic science regarding the basis of acquired immunity or the global
burden of disease is lacking. However, even with an
efficacy of 95% in preventing mortality and 60% in
preventing morbidity, few enteric pathogens cause
an aetiologic fraction of morbidity and mortality
of diarrhoeal disease large enough to compare with
interventions that are independent of aetiology,
JHPN
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Table 9. Unweighted priority scores (%) for development of novel vaccines to diminish the burden of
diarrhoeal disease
Overall
Criterion 1 Criterion 2 Criterion 3 Criterion 4 Criterion 5
Vaccine
priority
(%)
(%)
(%)
(%)
(%)
score (%)
New measles vaccines that will
be heat-stable and
able to immunize
newborns
76.7
77.8
59.3
50.0
61.7
65.1
Shigella
83.3
83.3
44.4
35.2
68.5
63.0
ETEC
66.7
63.0
37.0
42.6
68.5
55.6
EPEC
63.3
43.8
25.0
37.0
68.5
47.5
Norovirus
68.3
54.2
31.3
29.2
44.4
45.5
Helicobacter pylori
63.3
41.7
24.1
14.8
42.6
37.3
Entameoba histolytica
63.3
43.8
14.6
8.3
55.6
37.1
Campylobacter
56.7
41.7
12.5
13.0
51.9
35.1
EPEC=Enteropathogenic Escherichia coli; ETEC=Enterotoxigenic Escherichia coli
and scores for criterion 4 (maximum disease-reduction fraction) were, therefore, correspondingly low. While the aetiologic fractions may vary
somewhat by region, few pathogens cause more
than 10% of incident episodes globally, putting a
practical ceiling on the overall diarrhoeal diseaseburden reduction available by their control even
with high efficacy and coverage. Further stifling
the scoring were issues regarding to deliverability, and to a lesser extent, equity.

Water and sanitation
It is somewhat surprising to see the predominantly
intermediate ranks received by the research options
that could broadly be categorized as dealing with
water and sanitation, the theoretical mainstay to
control the transmission of enteric diseases. Research
options covered a broad range of issues, including those that deal with quality and quantity of
water (research option 7, 8, 9, 22, and 23; research
options addressing the improved disposal of human
excreta (research option 10, 11, 24, and 44); and
a single research option addressing handwashing
(research option 12). As a group, these obtained
high scores in terms of equity and answerability
and scores predominantly in the second quartile
for maximum disease-burden reduction but lower
scores in other categories, including deliverability
and sustainability.

Nutrition
Improving nutritional status has a key role in decreasing the burden of diarrhoeal disease. Two of
the top 10 priority scores, overall, went to research
options that included zinc, a micronutrient that
has shown effects in decreasing the duration of diVolume 27 | Number 3 | June 2009

arrhoeal episodes and the risk of developing persistent diarrhoea. Increasing the coverage of vitamin
A supplementation and increasing the energy-density of weaning foods in areas with food availability
received priority scores of 71.2% and 67.5% respectively and were in the top quartile of rankings. Research to improve the quality of diet in areas with
limited food availability obtained a more modest
priority score of 61.0%. Cash-transfer programmes
designed to improve diet in areas with restricted access were given a priority score of only 47.1% hampered in large part by the perceived problems in
delivery and maintenance of the programmes.

DISCUSSION
The research options that appear on the list are not
comprehensive. These are rather meant to be a selection of the top research options representative
of various strategies of diarrhoeal disease control.
These include a balance between the development
of new interventions with research that addresses
improved implementation of interventions that
have already been shown to be efficacious. We feel
that the structured nature of the process of scoring
research options leads to a significant improvement from previously-used methods involving
expert consensus. The output is a list of ranking
options developed by technical experts scoring
independently to avoid problems associated with
group dynamics in decision-making. The structure
of the scoring process minimizes bias through its
transparency and resulting accountability.
The prioritization of research options has important implications for the assignment of available
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funds that are intended for the control of diarrhoeal
disease and the improvement of child health. This
approach to improve the decision-making process
has steered away from informal meetings of experts
that were classically used because of concerns of
decision-making flaws resulting from both group
dynamics (i.e. groupthink) (11) and vested interest
in the development of programmes in the particular field of interest of the expert. The Delphi process was meant to overcome these shortcomings
through anonymity of scorers, structured feedback,
and progressive feedback to distill or focus-group
opinion. However, the Delphi output lacks the
transparency of the CHNRI process, and the reasons
behind the scorers’ decisions are unclear. While the
Delphi thereby works to obtain a consensus, the
CHNRI process generates a quantitative output
that allows for the calculation of uncertainty in the
evaluation of research options through analysis of
variance of the individual expert’s scores. Furthermore, the CHNRI process elucidates the specific
contexts within which the priorities are set (preferably with the investors in health research). It offers
an approach to systematic listing of large numbers
of research investment options and comparison
between options from different research domains
using the same set of criteria, thus balancing between high-risk and low-risk options. Its systematic
nature in scoring research options decreases individual bias while independent scoring by many
experts removes the possibility of a few individuals
dominating the decisions on priorities.
One of the shortcomings of this scoring exercise
done at this level and applied to a local level is related to problems of the context. When scoring is
done, as was the case here, to be broadly applied
to the majority of population of the developing
world, assumptions are made that may not be
truly representative of certain areas. A key example
of this relates to issues of deliverability, cost, and
sustainability. This criterion is the one most likely
to vary between areas with different levels of political stability, public infrastructure, and economic
resources. For these reasons, at the regional level, it
is worth having a group of experts re-score research
options for this particular criterion as this may optimize the overall evaluation of different research
options in local contexts. An excel file that facilitates this process is available at http://www.icddrb.
org/jhpn.
A second shortcoming of this exercise was the
limited availability of selected experts for the exercise. Although 19 experts were invited to partici330
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pate, only 10 individuals contributed their priority
scores. In the future, we would recommend linking
the scoring activity to a meeting to facilitate higher
participation rates among appropriate experts.
Despite limitations of the CHNRI process, it has
several advantages over existing priority-setting
techniques. First, the transparency of the process in
and of itself can be a roadmap to researchers and
potential funding agencies in the area of interest.
For example, if experts give a low scores for certain
research option relating to issues surrounding deliverability and equity, researchers in the area will be
stimulated to develop novel delivery strategies to
deliver the intervention to those with the greatest
need, and granting agencies can direct programme
announcements to fund these proposals. Like the
Delphi exercise, it controls the influence of group
dynamics, although it does so to a greater extent
because scorers are not ‘refocused’ or redirected by
serial scoring exercises.
It is clear that the domination of health policy
and systems research among those obtaining the
higher ranks is a consequence of results (effects on
the burden of disease) being expected by 2015. A
longer timeframe (e.g. 50 years) might allow more
long-term strategic events to obtain higher scores.
Furthermore, although the framework for scoring
is transparent and systematic and it follows that
rational answers to narrowly-formatted questions
minimize personal biases, there is a possibility that
a different group, composed of more policy-makers
and programme officers rather than the group that
preformed this exercise, may yield somewhat different results. Despite these limitations, we believe
that this priority-setting exercise is a useful guide
to investors in health research targeting diarrhoeal
disease, who hope to observe measurable results
prior to the end-date of the millennium development goals.
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